Quick Comparison

EGF (Epidermal Growth Factor)Vitamin K
Typical ConcentrationConcentrations vary by product (typically measured in ppm or sh-oligopeptide-1 percentage). Applied once or twice daily. Best used after procedures or on aging skin. Apply before oils/occlusives. Store in refrigerator for stability.Concentrations: 1-5% in eye creams and targeted treatments. Apply to under-eye area and areas with visible blood vessels. Results take 4-8 weeks of consistent use. Phytonadione (vitamin K1) is the most common topical form.
ApplicationTopical (serum, cream, ampoule). Apply to clean skin. Temperature-sensitive — some products require refrigeration.Topical (eye cream, serum). Apply gently to under-eye area and areas of concern.
Research Papers10 papers10 papers
Categories

Mechanism of Action

EGF (Epidermal Growth Factor)

EGF binds EGFR/ErbB1 on keratinocytes and fibroblasts, triggering dimerization and autophosphorylation. Activates MAPK/ERK (Ras-Raf-MEK-ERK) and PI3K/AKT pathways, promoting proliferation, migration (actin reorganization, focal adhesion turnover), and differentiation. Upregulates cyclin D1, inhibits p27. Stimulates fibroblast collagen types I/III and hyaluronic acid via HAS2. In wound healing, accelerates re-epithelialization via keratinocyte migration and reduces scarring via TGF-beta modulation. For anti-aging, promotes cellular renewal and extracellular matrix production. Theoretical cancer concern from EGFR's growth role — topical EGF has not been shown to penetrate to basal layer or systemic circulation significantly.

Vitamin K

Vitamin K (phytonadione/K1) is cofactor for gamma-glutamyl carboxylase, which carboxylates glutamic acid residues in clotting factors II, VII, IX, X and proteins S, C — essential for calcium binding and coagulation cascade activation. Topically promotes reabsorption of subcutaneous extravasated blood by activating local clotting cascades that convert leaked hemoglobin to biliverdin and bilirubin for clearance. Strengthens capillary walls, reduces vascular permeability. For vascular dark circles: improves vessel wall integrity, reduces hemosiderin deposition. Supports elastic fiber production through matrix Gla protein carboxylation. Has anti-inflammatory effects. Clinical use: bruising, post-procedure ecchymosis, periorbital vascular hyperpigmentation. Results require 4-8 weeks consistent application.

Risks & Safety

EGF (Epidermal Growth Factor)

Common

Very well-tolerated.

Serious

Theoretical concern about promoting growth of pre-existing skin cancers (unproven but debated).

Rare

Mild irritation.

Vitamin K

Common

Essentially none — very well-tolerated.

Serious

None documented topically.

Rare

Allergic contact dermatitis.

Full Profiles